Monday, September 28, 2009

Not Surprised On ASPM

When you see a buyout -- like ASPM up 55% on Covidien's $12/share offer, many traders probably think -- I wish I could have known about it.

Actually, I'm not surprised.  One of the blogs I follow had a write-up on ASPM about 17 days ago.  The author outlined why ASPM was undervalued.  He even suggested that ASPM could be a buyout target for a company like COV (the only buyer named in the article).  Unfortunately, I passed on the idea.

But at least I'm following the right people.

No comments: